吸入器在喘和COPD护理中的可持续性:系统性审查
Adeola Ayodotun Onasanya1, Yaser Haider2, Grace Peaston3,4
1Department of Applied Health Sciences, University of Birmingham, Birmingham, UK a.onasanya.1@bham.ac.uk.
BMJ open
|July 25, 2025
概括
在喘和COPD中持续使用吸入器需要更好地教育患者处理和临床医生的低碳处方培训. 这种方法提高了健康结果和环境可持续性.
科学领域:
- 环境健康 环境健康
- 呼吸系统医学 呼吸系统医学
- 可持续的医疗保健 可持续的医疗保健
背景情况:
- 喘和慢性阻塞性肺病 (COPD) 的吸入器对环境产生重大影响.
- 当前的处方,使用和处置做法有助于这些环境问题.
- 对于吸入器管理对环境足迹的认识有限.
研究的目的:
- 评估吸入器在喘和COPD管理中的可持续性.
- 分析吸入器的设计,处方,使用,处置和回收如何影响健康和环境结果.
- 通过使用人民-流程-产品 (PPP) 框架,识别可操作的改进机会.
主要方法:
- 对2014年4月至2024年4月期间发表的文献进行了系统审查.
- 包括涉及喘或COPD患者和检查吸入器可持续性的医疗保健专业人员的研究.
- 从63项研究中使用PPP框架提取和叙述合成数据.
主要成果:
- 患者和临床医生对环境影响的认识有限;超过75%的患者将吸入器丢弃在家用垃圾中.
- 转换为干粉吸入器 (DPI) 或软雾吸入器 (SMI) 改善了附着性和喘控制,受可用性的影响.
- 与压力计量剂量吸入剂 (pMDIs) 相比,DPI和SMI的碳足迹较低,短效β-激动剂 (SABA) 的pMDIs排放量最高.
结论:
- 提高患者对可持续吸入器使用和处置的教育至关重要.
- 对医疗保健专业人员在低碳处方方面进行有针对性的培训是必不可少的.
- 这些干预措施对于改善呼吸道疾病管理中的临床益处和环境可持续性至关重要.
相关概念视频
Inhaled Medications
394
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
394
COPD: Management Using Bronchodilators and Corticosteroids
314
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
314
Chronic Obstructive Pulmonary Disease-V: Management
2.7K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.7K
Asthma-IV: Diagnostic and Management
2.6K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K
Chronic Obstructive Pulmonary Disease-V: Nursing Management
4.3K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
4.3K
Asthma: Pathogenesis and Management
597
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
597


